This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Costa-Santos, M. Articles by Auchus, R. J. Search for Related Content PubMed PubMed Citation Articles by Costa-Santos, M. Articles by Auchus, R. J.

Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency

Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Federal University of Sao Paulo (M.C.-S., C.E.K.), Sao Paulo, Brazil 04039-034; and Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center (R.J.A.), Dallas, Texas 75390-8857

Address all correspondence and requests for reprints to: Richard J. Auchus, M.D., Ph.D., Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8857. E-mail: richard.auchus{at}utsouthwestern.edu.

We performed molecular genetic analysis of 24 subjects from 19 families with 17-hydroxylase deficiency in Brazil. Of 7 novel CYP17 mutations, 2 (W406R and R362C) account for 50% and 32% of the mutant alleles, respectively. Both mutations were completely inactive when studied in COS-7 cells and yeast microsomes; however, phenotypic features varied among subjects. Some 46,XY individuals with these genotypes had ambiguous genitalia, and other subjects had normal blood pressure and/or serum potassium. We found mutations W406R and R362C principally in families with Spanish and Portuguese ancestry, respectively, suggesting that two independent founder effects contribute to the increased prevalence of 17-hydroxylase deficiency in Brazil. Mutations Y329D and P428L retained a trace of activity, yet the two individuals with these mutations had severe hypertension and hypokalemia. The 46,XX female with mutation Y329D reached Tanner stage 5, whereas the 46,XY subject with mutation P428L remained sexually infantile. The severity of hypertension, hypokalemia, 17-deoxysteroid excess, and sex steroid deficiency varied, even among patients with completely inactive CYP17 protein(s). Spontaneous sexual development occurred only in 46,XX females with partial deficiencies. We conclude that other factors, in addition to CYP17 genotype, contribute to the phenotype of individual patients with 17-hydroxylase deficiency.

This work was supported by NIH Grants K08-DK-02387 and R03-DK-56641 (to R.J.A.) and by grants from Fundação de Amparo à Pequisa do Estado de Sâo Paulo (96/7449-6) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (0690/00-7; to C.E.K.).

Results from this work were presented in abstract form at the 83rd Annual Meeting of The Endocrine Society, Denver, CO, June 2001.

Abbreviations: CAH, Congenital adrenal hyperplasia; CPR, cytochrome P450-oxidoreductase; DOC, 11-deoxycorticosterone; 17OHD, 17-hydroxylase deficiency.

This article has been cited by other articles:

				S. Turan, A. Bereket, T. Guran, T. Akcay, M. Papari-Zareei, and R. J Auchus Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair Eur. J. Endocrinol., February 1, 2009; 160(2): 325 - 330. [Abstract] [Full Text] [PDF]

				V. W. Setiawan, F. R. Schumacher, C. A. Haiman, D. O. Stram, D. Albanes, D. Altshuler, G. Berglund, J. Buring, E. E. Calle, F. Clavel-Chapelon, et al. CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2237 - 2246. [Abstract] [Full Text] [PDF]

				S. Rosa, C. Duff, M. Meyer, M. Lang-Muritano, G. Balercia, M. Boscaro, A. Kemal Topaloglu, R. Mioni, F. Fallo, L. Zuliani, et al. P450c17 Deficiency: Clinical and Molecular Characterization of Six Patients J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1000 - 1007. [Abstract] [Full Text] [PDF]

				B. Ergun-Longmire, R. Auchus, M. Papari-Zareei, S. Tansil, R. C. Wilson, and M. I. New Two Novel Mutations Found in a Patient with 17{alpha}-Hydroxylase Enzyme Deficiency J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4179 - 4182. [Abstract] [Full Text] [PDF]

				J. Yang, B. Cui, S. Sun, T. Shi, S. Zheng, Y. Bi, J. Liu, Y. Zhao, J. Chen, G. Ning, et al. Phenotype-Genotype Correlation in Eight Chinese 17{alpha}-Hydroxylase/17,20 Lyase-Deficiency Patients with Five Novel Mutations of CYP17A1 Gene J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3619 - 3625. [Abstract] [Full Text] [PDF]

				J.-Q. Wei, J.-L. Wei, W.-C. Li, Y.-S. Bi, and F.-C. Wei Genotyping of Five Chinese Patients with 17{alpha}-Hydroxylase Deficiency Diagnosed through High-Performance Liquid Chromatography Serum Adrenal Profile: Identification of Two Novel CYP17 Mutations J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3647 - 3653. [Abstract] [Full Text] [PDF]

				A. M. Brooke, N. F. Taylor, J. H. Shepherd, M. E. Gore, T. Ahmad, L. Lin, G. Rumsby, M. Papari-Zareei, R. J. Auchus, J. C. Achermann, et al. A Novel Point Mutation in P450c17 (CYP17) Causing Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2428 - 2431. [Abstract] [Full Text] [PDF]

				C. M. Small, M. Marcus, S. L. Sherman, A. K. Sullivan, A. K. Manatunga, and H. S. Feigelson CYP17 genotype predicts serum hormone levels among pre-menopausal women Hum. Reprod., August 1, 2005; 20(8): 2162 - 2167. [Abstract] [Full Text] [PDF]

				K. Mussig, S. Kaltenbach, F. Machicao, C. Maser-Gluth, M. F. Hartmann, S. A. Wudy, G. Schnauder, H.-U. Haring, F. J. Seif, and B. Gallwitz 17{alpha}-Hydroxylase/17,20-Lyase Deficiency Caused by a Novel Homozygous Mutation (Y27Stop) in the Cytochrome CYP17 Gene J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4362 - 4365. [Abstract] [Full Text] [PDF]

				M. Taniyama, M. Tanabe, H. Saito, Y. Ban, H. Nawata, and T. Yanase Subtle 17{alpha}-Hydroxylase/17,20-Lyase Deficiency with Homozygous Y201N Mutation in an Infertile Woman J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2508 - 2511. [Abstract] [Full Text] [PDF]

				W. L. Miller Steroid 17{alpha}-Hydroxylase Deficiency--Not Rare Everywhere J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 40 - 42. [Full Text] [PDF]

				M. Costa-Santos, C. E. Kater, E. P. Dias, and R. J. Auchus Two Intronic Mutations Cause 17-Hydroxylase Deficiency by Disrupting Splice Acceptor Sites: Direct Demonstration of Aberrant Splicing and Absent Enzyme Activity by Expression of the Entire CYP17 Gene in HEK-293 Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 43 - 48. [Abstract] [Full Text] [PDF]